Ecolab Inc. (ECL)
NYSE: ECL · Real-Time Price · USD
253.49
-2.85 (-1.11%)
Oct 25, 2024, 4:00 PM EDT - Market closed
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Industrial Revenue | 7.47B | 7.34B | 7.21B | 7.12B | 7.07B | 6.95B | 6.81B | 6.68B | ||||||
| Industrial Revenue Growth | 5.66% | 5.62% | 5.91% | 6.59% | 8.43% | 9.04% | 9.09% | 9.24% | ||||||
| Institutional and Specialty Revenue | 5.23B | 5.14B | 4.99B | 4.83B | 4.69B | 4.54B | 4.42B | 4.35B | ||||||
| Institutional and Specialty Revenue Growth | 11.50% | 13.04% | 12.90% | 11.09% | 10.09% | 10.61% | 11.84% | 14.88% | ||||||
| Healthcare and Lifesciences Revenue | 1.58B | 1.58B | 1.48B | 1.47B | 1.43B | 1.43B | 1.51B | 1.41B | ||||||
| Healthcare and Lifesciences Revenue Growth | 10.96% | 10.95% | -1.99% | 4.32% | 6.45% | 14.04% | 27.84% | 17.49% | ||||||
| Other Revenue | 1.31B | 1.38B | 1.44B | 1.41B | 1.39B | 1.36B | 1.32B | 1.30B | ||||||
| Other Revenue Growth | -5.27% | 1.40% | 8.93% | 8.46% | 8.65% | 9.53% | 8.67% | 10.30% | ||||||
| Corporate Revenue | - | - | 69.00M | 82.80M | 67.80M | 51.10M | 62.20M | - | ||||||
| Corporate Revenue Growth | - | - | 10.93% | - | - | -63.71% | -55.32% | - |
Operating Income by Segment
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Institutional and Specialty Operating Income | 1.06B | 943.40M | 821.30M | 749.30M | 695.50M | 638.80M | 623.80M | 615.50M | ||||||
| Institutional and Specialty Operating Income Growth | 51.70% | 47.68% | 31.66% | 21.74% | 13.50% | 6.47% | 13.19% | 26.15% | ||||||
| Industrial Operating Income | 1.18B | 1.13B | 1.08B | 1.03B | 1.01B | 978.10M | 951.50M | 956.00M | ||||||
| Industrial Operating Income Growth | 17.15% | 15.27% | 13.53% | 7.55% | 5.83% | -1.31% | -6.74% | -10.21% | ||||||
| Other Operating Income | 252.30M | 252.90M | 254.30M | 242.50M | 232.60M | 220.80M | 208.50M | 195.70M | ||||||
| Other Operating Income Growth | 8.47% | 14.54% | 21.97% | 23.91% | 21.53% | 15.30% | 11.80% | 4.82% | ||||||
| Healthcare and Lifesciences Operating Income | 162.50M | 161.50M | 159.70M | 172.90M | 160.30M | 184.40M | 193.50M | 161.20M | ||||||
| Healthcare and Lifesciences Operating Income Growth | 1.37% | -12.42% | -17.47% | 7.26% | -3.55% | 17.15% | 22.39% | -12.20% | ||||||
| Corporate Operating Income | -291.10M | -291.90M | -289.50M | -371.30M | -355.60M | -362.50M | -414.80M | -377.80M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.